The future role of genetic screening to detect newborns at risk of childhood-onset hearing loss

References

• Abe S., Yamaguchi T. & Usami S-I. 2007. Application of deafness diagnostic screening panel based on deafness mutation/gene database using Invader Assay. Genet Test, 11, 333–340.
   PubMedGoogle Scholar
• Andermann A., Blancquaert I., Beauchamp S. & Costea I. 2011. Guiding policy decisions for genetic screening: Developing a systematic and transparent approach. Public Health Genomics, 14, 9–16.
   PubMed Web of Science ®Google Scholar
• Bamford J., Fortnum H., Bristow K., Smith J., Vamvakas G. . 2007. Current practice, accuracy, effectiveness, and cost effectiveness of the school entry hearing screen. Health Technol Assess, 11(32), 1–168.
   PubMed Web of Science ®Google Scholar
• Biesecker L.G. 2010. Exome sequencing makes medical genomics a reality. Nat Genet, 42, 13–14.
   PubMed Web of Science ®Google Scholar
• Bitner-Glindzicz M. 2002. Hereditary deafness and phenotyping in humans. Br Med Bull, 63, 73–94.
   PubMed Web of Science ®Google Scholar
• Bitner-Glindzicz M., Pembrey M., Duncan A., Heron J., Ring S.M. . 2009. Prevalence of mitochondrial 1555A→G mutation in European children. NEJM, 306, 640–642.
   Google Scholar
• CGC Genetics. Molecular diagnosis of congenital deafness (syndromic and nonsysndromic) by Array CGC. Available at: www.CGCGenetics.com. Accessed 25/11/2010.
   Google Scholar
• Ching Y.C. 2012. The Longitudinal Outcomes of Children with Hearing Impairment (LOCHI) study. Available at: http://www.outcomes.nal.gov.au/Publications_Presentations_Newsletters/2012_Yr%203%20outcomes_FirstVoice%20meeting.pdf Accessed 21/07/2012.
   Google Scholar
• Cryns K. & Van Camp G. 2004. Deafness genes and their diagnostic applications. Audiol Neurootol, 9, 2–22.
   PubMed Web of Science ®Google Scholar
• Department of Health. 2003. Our Inheritance, Our Future: Realising the Potential of Genetics in the NHS. London: HMSO.
   Google Scholar
• Dhondt J-L. 2007. Neonatal screening: from the ‘Guthrie age’ to the ‘genetic age’. J Inherit Metab Dis, 30, 418–422.
   PubMed Web of Science ®Google Scholar
• Durante-Mangoni E., Grammatikos A., Utili R. & Falagas M.E. 2009. Do we still need aminoglycosides?Int J Antimicrob Agents, 33, 201–205.
   PubMed Web of Science ®Google Scholar
• Gardener P., Oitmaa E., Messner A.Hoefsloot L.Metspalu A. . 2006. Simultaneous multigene mutation detection in patients with sensorineural hearing loss through a novel diagnostic microarray: A new approach for newborn screening follow-up. Pediatrics, 118, 985–994.
   PubMed Web of Science ®Google Scholar
• Goel V. 2001. Appraising organised screening programmes for testing for genetic susceptibility to cancer. BMJ, 322, 1174–1178.
   PubMedGoogle Scholar
• Green G.E., Scott D.A., McDonald J.M., Woodworth G.G., Sheffield V.C. . 1999. Carrier rates in the Midwestern United States for GJB2mutations causing inherited deafness. JAMA, 281, 2211–2216.
   PubMed Web of Science ®Google Scholar
• Hilgert N., Smith R.J. & Van Camp G. 2009. Forty six genes causing nonsyndromic hearing impairment: Which ones should be analysed in DNA diagnostics?Mutat Res, 681, 189–196.
   PubMed Web of Science ®Google Scholar
• Hutchin T., Coy N.N., Conlon H., Telford E., Bromelow K. . 2005. Assessment of the genetic causes of recessive childhood non-syndromic deafness in the UK: Implications for genetic testing. Clin Genet, 68, 506–512.
   PubMed Web of Science ®Google Scholar
• Hutchin T., Haworth I., Higashi K., Fischel-Ghodsian N., Stoneking M. . 1993. A molecular basis for human hypersensitivity to aminoglycoside antibiotics. Nucleic Acids Res, 21, 4174–4179.
   PubMed Web of Science ®Google Scholar
• Khoury M.J., McCabe L.L. & McCabe E.R.B. 2003. Population screening in the age of genomic medicine. NEJM, 348, 50–58.
   PubMed Web of Science ®Google Scholar
• Kothiyal P., Cox S., Ebert J.Husami A., Kenna M.A. . 2010. High-throughput detection of mutations responsible for childhood hearing loss using resequencing microarrays. BMC Biotechnology, 10, 10.
   PubMed Web of Science ®Google Scholar
• Lench N., Houseman M., Newton V., Van Camp G. & Mueller R. 1998. Connexin-26 mutations in sporadic non-syndromal sensorineural deafness. Lancet, 351, 415.
   PubMed Web of Science ®Google Scholar
• Li C-X., Pan Q., Guo Y-G., Li Y., Gao H-F. . 2008. Construction of a multiplex allele-specific PCR-based universal array (ASPUA) and its application to hearing loss screening. Hum Mutat, 29, 306–314.
   PubMed Web of Science ®Google Scholar
• Metzker M.L. 2005. Emerging technologies in DNA sequencing. Genome Res, 15, 1767–1776.
   PubMed Web of Science ®Google Scholar
• Morozova O. & Marra M.A. 2008. Applications of next-generation sequencing technologies in functional genomics. Genomics, 92, 255–264.
   PubMed Web of Science ®Google Scholar
• Ng S.B., Nickerson D.A., Bamshad M.J. & Shendure J. 2010. Massively parallel sequencing and rare disease. Hum Mol Genet, 19(R2), R119–124.
   Google Scholar
• NHS Newborn Hearing Screening Programme. NHS Newborn Hearing Screening Programme 2010–11 Annual report and 2009–10 Data Report. Available at: www.hearing.screening.nhs.uk/publications. Accessed 23/01/ 2012.
   Google Scholar
• Nuffield Council on Bioethics. 2006. Genetic Screening: A Supplement to the 1993 Report by the Nuffield Council of Bioethics. London: Nuffield Council of Bioethics.
   Google Scholar
• Otogenetics Corporation. Available at: www.otogenetics.com/index_htm_files/Deafness_80_genelist.pdf Accessed 07/06/2011.
   Google Scholar
• Partners Healthcare. Harvard Medical School. Otochip Test for hearing lossand Usher Syndrome. Available at: pcpgm.partners.org/lmm/tests/ hearing-loss/OtoChip. Accessed 25/11/2010.
   Google Scholar
• Pediatrix Medical Group. Soundgene Screening Panel. Available at: www.pediatrix.com/body.cfm?id = 2889&0TopID = 50. Accessed 17/12/2010.
   Google Scholar
• Rodriguez-Paris J., Pique L., Colen T., Roberson J., Gardener P. . 2010. Genotyping with a 198 mutation arrayed primer extension array for hereditary hearing loss: Assessment of its diagnostic value for medical practice. PLoS One, 5, e11804.
   Web of Science ®Google Scholar
• Ross L.F. 2006. Screening for conditions that do not meet the Wilson and Junger Criteria: The case of Duchenne muscular dystrophy. Am J Med Genet, 140A, 914–922.
   Web of Science ®Google Scholar
• Shearer A.E., DeLuca A.P., Hildebrand M.S., Taylor K.R., Gurrola II J. . 2010. Comprehensive genetic testing for hereditary hearing loss using massively parallel sequencing. Proc Natl Acad Sci USA, 107, 21104–21109.
   PubMed Web of Science ®Google Scholar
• Siemering K., Manji S.S.M., Hutchinson W.M., Sart D.D., Phelan D. . 2006. Detection of mutations in genes associated with hearing loss using a microarray-based approach. J Mol Diagn, 8, 483–489.
   PubMed Web of Science ®Google Scholar
• Van Camp G., Willems P.J., Smith R.J. 1997. Non-syndromic hearing impairment: unparalleled heterogeneity. Am J Hum Genet, 60, 758–764.
   PubMed Web of Science ®Google Scholar
• Wellcome Trust. Genomics – the next generation. Available at: www.wellcome.ac.uk/News/2009/Features/WTX056032.htmAccessed 17/12/2010.
   Google Scholar
• Wilson J.M.G., Junger G. (1968). Principles and Practice of Screening for Disease. Geneva: World Health Organisation.
   Google Scholar
• Wright C., Burton H., Hall A., Moorthie S., Pokorska-Bocci A., . 2011. Next steps in the sequence. The implications of whole genome sequencing for health in the UK. Cambridge: PHG Foundation.
   Google Scholar
• Wu C-C., Hung C-C., Lin S-Y., Hsieh W-U., Tsao P-O., . 2011. Newborn genetic screening for hearing impairment: A preliminary study at a tertiary center. PLoS One, 6, e23314.
   Web of Science ®Google Scholar
• Zelante L., Gasparini P., Estivill X., Melchionda S., D’Agruma L., . 1997. Connexin 26 mutations associated with the most common form of non-syndromic neurosensory autosomal recessive deafness (DFNB1) in Mediterraneans. Hum Mol. Genet, 6, 1606–1609.
   Web of Science ®Google Scholar